Compliance with American College of Chest Physicians (ACCP) recommendations for thromboembolic prophylaxis in the intensive care unit: a level I trauma center experience.

Chemoprophylaxis Intensive care unit Venous thromboembolism

Journal

Patient safety in surgery
ISSN: 1754-9493
Titre abrégé: Patient Saf Surg
Pays: England
ID NLM: 101319176

Informations de publication

Date de publication:
25 Mar 2021
Historique:
received: 11 01 2021
accepted: 16 03 2021
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 27 3 2021
Statut: epublish

Résumé

Recommendations are for nearly universal venous thromboembolism (VTE) prophylaxis in critically ill hospitalized patients because of their well-recognized risks. In those intensive care units (ICUs) where patient care is more uniformly directed, it may be expected that VTE prophylaxis would more closely follow this standard over units that are less uniform, such as open-model ICUs. This was a retrospective cohort study on all patients aged 18+ admitted to an open ICU between 6/1/2017 and 5/31/2018. Patients were excluded if they had instructions to receive comfort measures only or required therapeutic anticoagulant administration. Prophylaxis administration practices, including administration of mechanical and/or pharmacologic prophylaxis and delayed (≥48 h post-ICU admission) initiation of pharmacologic prophylaxis, were compared between patients admitted to the ICU by the trauma service versus other departments. Root causes for opting out of pharmacological prophylaxis were documented and compared between the two study groups. One-hundred two study participants were admitted by the trauma service, and 98 were from a non-trauma service. Mechanical (98% trauma vs. 99% non-trauma, P = 0.99) and pharmacologic (54% vs. 44%, P = 0.16) prophylaxis rates were similar between the two admission groups. The median time from ICU admission to pharmacologic prophylaxis initiation was 53 h for the trauma service and 10 h for the non-trauma services (P ≤ 0.01). In regression analyses, trauma-service admission (odds ratio (OR) = 2.88, 95% confidence interval (CI) 1.21-6.83) and increasing ICU length of stay (OR = 1.13, 95% CI 1.05-1.21) were independently associated with pharmacologic prophylaxis use. Trauma-service admission (OR = 8.30, 95% CI 2.18-31.56) and increasing hospital length of stay (OR = 1.15, 95% CI 1.03-1.28) were independently associated with delayed prophylaxis initiation. Overall, the receipt of VTE prophylaxis of any type was close to 100%, due to the nearly universal use of mechanical compression devices among ICU patients in this study. However, when examining pharmacologic prophylaxis specifically, the rate was considerably lower than is currently recommended: 54% among the trauma services and 44% among non-trauma services.

Sections du résumé

BACKGROUND BACKGROUND
Recommendations are for nearly universal venous thromboembolism (VTE) prophylaxis in critically ill hospitalized patients because of their well-recognized risks. In those intensive care units (ICUs) where patient care is more uniformly directed, it may be expected that VTE prophylaxis would more closely follow this standard over units that are less uniform, such as open-model ICUs.
METHODS METHODS
This was a retrospective cohort study on all patients aged 18+ admitted to an open ICU between 6/1/2017 and 5/31/2018. Patients were excluded if they had instructions to receive comfort measures only or required therapeutic anticoagulant administration. Prophylaxis administration practices, including administration of mechanical and/or pharmacologic prophylaxis and delayed (≥48 h post-ICU admission) initiation of pharmacologic prophylaxis, were compared between patients admitted to the ICU by the trauma service versus other departments. Root causes for opting out of pharmacological prophylaxis were documented and compared between the two study groups.
RESULTS RESULTS
One-hundred two study participants were admitted by the trauma service, and 98 were from a non-trauma service. Mechanical (98% trauma vs. 99% non-trauma, P = 0.99) and pharmacologic (54% vs. 44%, P = 0.16) prophylaxis rates were similar between the two admission groups. The median time from ICU admission to pharmacologic prophylaxis initiation was 53 h for the trauma service and 10 h for the non-trauma services (P ≤ 0.01). In regression analyses, trauma-service admission (odds ratio (OR) = 2.88, 95% confidence interval (CI) 1.21-6.83) and increasing ICU length of stay (OR = 1.13, 95% CI 1.05-1.21) were independently associated with pharmacologic prophylaxis use. Trauma-service admission (OR = 8.30, 95% CI 2.18-31.56) and increasing hospital length of stay (OR = 1.15, 95% CI 1.03-1.28) were independently associated with delayed prophylaxis initiation.
CONCLUSIONS CONCLUSIONS
Overall, the receipt of VTE prophylaxis of any type was close to 100%, due to the nearly universal use of mechanical compression devices among ICU patients in this study. However, when examining pharmacologic prophylaxis specifically, the rate was considerably lower than is currently recommended: 54% among the trauma services and 44% among non-trauma services.

Identifiants

pubmed: 33766093
doi: 10.1186/s13037-021-00288-4
pii: 10.1186/s13037-021-00288-4
pmc: PMC7993448
doi:

Types de publication

Journal Article

Langues

eng

Pagination

13

Références

Cureus. 2018 Sep 21;10(9):e3341
pubmed: 30473974
Clin Colon Rectal Surg. 2013 Sep;26(3):153-9
pubmed: 24436666
J Clin Oncol. 2020 Feb 10;38(5):496-520
pubmed: 31381464
Ann Thorac Med. 2011 Jul;6(3):105-6
pubmed: 21760838
Emerg (Tehran). 2017;5(1):e13
pubmed: 28286820
J Korean Med Sci. 2016 Nov;31(11):1828-1837
pubmed: 27709864
World Neurosurg. 2018 Feb;110:e339-e345
pubmed: 29129761
JAMA Surg. 2014 Apr;149(4):365-70
pubmed: 24577627
Semin Thromb Hemost. 2015 Feb;41(1):68-74
pubmed: 25594495
Turk J Haematol. 2019 May 01;36(3):193-198
pubmed: 31042860
J Intensive Care Med. 2019 Nov-Dec;34(11-12):877-888
pubmed: 30165770
Crit Care. 2012 Jul 26;16(4):228
pubmed: 22839302
Ann Surg. 2010 Mar;251(3):393-6
pubmed: 20083996
Blood Adv. 2020 Oct 13;4(19):4693-4738
pubmed: 33007077
Crit Care. 2021 Jan 12;25(1):27
pubmed: 33436012
Crit Care. 2015 Aug 18;19:287
pubmed: 26283414
J Clin Med. 2020 Aug 01;9(8):
pubmed: 32752154
Blood Adv. 2019 Dec 10;3(23):3898-3944
pubmed: 31794602
Blood Transfus. 2015 Oct;13(4):559-68
pubmed: 26513770
Intensive Care Med. 2019 Feb;45(2):211-222
pubmed: 30707246
Circulation. 2013 Aug 27;128(9):1003-20
pubmed: 23852609
Curr Opin Crit Care. 2020 Dec;26(6):640-647
pubmed: 33027148

Auteurs

Michael J Waxman (MJ)

Medical-Surgical Intensive Care Unit and Progressive Care Unit, Research Medical Center, Kansas City, MO, USA.

Daniel Griffin (D)

Pulmonary and Critical Care, University of Missouri School of Medicine, Kansas City, MO, USA.

Erica Sercy (E)

Trauma Research Department, Research Medical Center, Kansas City, MO, USA.

David Bar-Or (D)

Trauma Research Department, Research Medical Center, Kansas City, MO, USA. davidbme49@gmail.com.
Injury Outcomes Network and Trauma Research LLC, 501 E. Hampden Avenue, Room 4-454, Englewood, Colorado, 80113, USA. davidbme49@gmail.com.

Classifications MeSH